Latest news
Amneal Pharmaceuticals' (NASDAQ:AMRX) Strong Earnings Are Of Good Quality - simplywall.stsimplywall.st · Fri, 07 Aug 2026 12:03:40 GMT5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call - StockStoryStockStory · Wed, 05 Aug 2026 07:00:00 GMTUBS Adjusts Price Target on Amneal Pharmaceuticals to $25 From $23, Maintains Buy Rating - MoomooMoomoo · Mon, 03 Aug 2026 13:48:29 GMTAmneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9% - The Globe and MailThe Globe and Mail · Thu, 30 Jul 2026 07:00:00 GMTAmneal Pharmaceuticals (NASDAQ:AMRX) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeatMarketBeat · Thu, 30 Jul 2026 07:00:00 GMTGoldman Sachs Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX) - The Globe and MailThe Globe and Mail · Tue, 28 Jul 2026 11:46:00 GMT